GENE ONLINE|News &
Opinion
Blog

2022-09-16| COVID-19Special

The COVID-19 Pandemic: Is Omicron the Last Variant?

by Max Heirich
Share To
The COVID-19 pandemic saw the rise of multiple strains that put the companies manufacturing vaccines through their paces to keep up. With the FDA approving new vaccines for the latest substrains of the Omicron Variant, it seems that COVID-19 Cases are finally slowing down. These Emergency Use Authorizations were pushed through in a manner of days, marking them as some of the fastest ever in FDA history. However, they were based upon mountains of prior research done on their predecessors for prior strains as well as the heavily mutated Omicron Strains.
How do these vaccines function differently from their prior counterparts? And will these boosters bring about the end of the COVID-19 pandemic after so many strain mutations?

GO Prime with only $1.49 now

LATEST
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
2024-06-18
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
EVENT
Scroll to Top